国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
8期
1154-1155
,共2页
倍他乐克%洛丁新%治疗%老年CHF%心功能
倍他樂剋%洛丁新%治療%老年CHF%心功能
배타악극%락정신%치료%노년CHF%심공능
Metoprolol%Lotensin%Treatment%Elderly CHF%Cardiac function
目的 探讨倍他乐克联合洛丁新治疗老年慢性充血性心力衰竭(CHF)的临床效果及安全性.方法 将我院70例老年CHF患者随机分为观察组和对照组,均予以常规抗心力衰竭治疗,观察组在此基础上加用倍他乐克和洛丁新,在治疗前后测定两组左心室收缩末期容积(LVESV)和左心室舒张末期容积(LVEDV),并进行临床疗效评价.结果 两组治疗后LVESV较治疗前均有明显改善(P＜0.01);治疗后观察组LVESV改善明显优于对照组(P＜0.01);观察组临床总有效率为88.57％,明显高于对照组的74.29％(P＜0.05).结论 倍他乐克联合洛丁新能明显改善CHF患者的临床症状和心功能.
目的 探討倍他樂剋聯閤洛丁新治療老年慢性充血性心力衰竭(CHF)的臨床效果及安全性.方法 將我院70例老年CHF患者隨機分為觀察組和對照組,均予以常規抗心力衰竭治療,觀察組在此基礎上加用倍他樂剋和洛丁新,在治療前後測定兩組左心室收縮末期容積(LVESV)和左心室舒張末期容積(LVEDV),併進行臨床療效評價.結果 兩組治療後LVESV較治療前均有明顯改善(P＜0.01);治療後觀察組LVESV改善明顯優于對照組(P＜0.01);觀察組臨床總有效率為88.57％,明顯高于對照組的74.29％(P＜0.05).結論 倍他樂剋聯閤洛丁新能明顯改善CHF患者的臨床癥狀和心功能.
목적 탐토배타악극연합락정신치료노년만성충혈성심력쇠갈(CHF)적림상효과급안전성.방법 장아원70례노년CHF환자수궤분위관찰조화대조조,균여이상규항심력쇠갈치료,관찰조재차기출상가용배타악극화락정신,재치료전후측정량조좌심실수축말기용적(LVESV)화좌심실서장말기용적(LVEDV),병진행림상료효평개.결과 량조치료후LVESV교치료전균유명현개선(P＜0.01);치료후관찰조LVESV개선명현우우대조조(P＜0.01);관찰조림상총유효솔위88.57％,명현고우대조조적74.29％(P＜0.05).결론 배타악극연합락정신능명현개선CHF환자적림상증상화심공능.
Objective To investigate the therapeutic effects and safety of Metoprolol combined with Lotensin in treating elderly patients with chronic congestive heart failure (CHF).Methods 70 cases of elderly CHF patients were divided into the observation group and the control groups randomly,both received conventional anti-heart failure treatment.Based on this,the patients of the observation group took Metoprolol combined with Lotensin.Measured the left ventricular end-systolic volume (LVESV) and the left ventricular end-diastolic volume (LVEDV) before and after treatment,and made the clinical evaluation.Results After treatment,LVESV were significantly better in two groups(P ＜0.01),while LVESV of observation group improved more obviously than the control group(P ＜0.01).The total effective rate of the observation group was 88.57％,much higher than that of the control group(74.29％)(P ＜ 0.05).Conclusion Metoprolol combined with Lotensin can significantly improve the clinical symptoms and cardiac function of the patients with CHF.
